Allogene Therapeutics ALLO SEC Filings

NASDAQ ALLO
$0.90 -0.03 (-3.41%)
At close: Nov 11, 2026 · 4:00 PM EST
EDGAR Disclosures

SEC Filings

Source SEC EDGAR

Every SEC filing Allogene Therapeutics, Inc. (ALLO) has made, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

Form Type
# Form Type Form Group Accession Date Filing Index
110-QQuarterly & Annual Report0001628280-26-071191Nov 6, 2026 10:31 PM
28-KCurrent Report0001628280-26-071040Nov 5, 2026 4:09 PM
3SCHEDULE 13GBeneficial Ownership Report0002012383-26-003872Oct 27, 2026 9:25 PM
44Insider Transaction0001491874-26-000005Oct 23, 2026 8:48 PM
5144Insider Transaction0001491874-26-000003Oct 21, 2026 3:48 AM
6SCHEDULE 13DBeneficial Ownership Report0001999371-26-021654Sep 30, 2026 8:18 PM
78-KCurrent Report0001193125-26-379423Sep 2, 2026 12:35 PM
84Insider Transaction0001628280-26-058920Aug 25, 2026 8:43 PM
9144Insider Transaction0001737287-26-000023Aug 21, 2026 11:26 PM
10EFFECTOthers9999999995-26-002725Aug 20, 2026 4:15 AM
11SCHEDULE 13GBeneficial Ownership Report0001231919-26-000912Aug 14, 2026 8:28 PM
12S-3Prospectus0001628280-26-056232Aug 12, 2026 8:22 PM
1310-QQuarterly & Annual Report0001628280-26-056213Aug 12, 2026 8:17 PM
148-KCurrent Report0001628280-26-056198Aug 12, 2026 8:12 PM
15SCHEDULE 13GBeneficial Ownership Report0001296549-26-000008Aug 7, 2026 12:20 AM
16SCHEDULE 13GBeneficial Ownership Report0000093751-26-000405Aug 7, 2026 12:33 PM
174Insider Transaction0001851044-26-000005Jul 6, 2026 9:51 PM
184Insider Transaction0001221355-26-000002Jun 23, 2026 8:35 PM
194Insider Transaction0001737287-26-000021Jun 23, 2026 8:34 PM
204Insider Transaction0001737287-26-000019Jun 23, 2026 8:33 PM
214Insider Transaction0001197020-26-000002Jun 23, 2026 8:32 PM
224Insider Transaction0001700969-26-000002Jun 23, 2026 8:29 PM
234Insider Transaction0001548072-26-000002Jun 23, 2026 8:28 PM
244Insider Transaction0001764157-26-000004Jun 23, 2026 8:26 PM
258-KCurrent Report0001628280-26-044618Jun 22, 2026 8:05 PM
26424B5Prospectus0001628280-26-044616Jun 22, 2026 8:03 PM
27DEFA14AOthers0001193125-26-245501May 28, 2026 9:09 PM
288-KCurrent Report0001193125-26-245484May 28, 2026 9:06 PM
29DEFA14AOthers0001628280-26-036992May 21, 2026 12:00 AM
30SCHEDULE 13GBeneficial Ownership Report0001104659-26-062730May 15, 2026 8:47 PM
31SCHEDULE 13GBeneficial Ownership Report0000902664-26-002534May 15, 2026 8:31 PM
32SCHEDULE 13GBeneficial Ownership Report0001296549-26-000006May 13, 2026 11:11 PM
33SCHEDULE 13GBeneficial Ownership Report0001611024-26-000005May 13, 2026 8:55 PM
3410-QQuarterly & Annual Report0001628280-26-034585May 13, 2026 8:05 PM
358-KCurrent Report0001628280-26-034583May 13, 2026 8:03 PM
36ARSOthers0001628280-26-028957Apr 30, 2026 8:41 PM
37DEFA14AOthers0001628280-26-028953Apr 30, 2026 8:40 PM
38DEF 14AOthers0001628280-26-028948Apr 30, 2026 8:37 PM
39SCHEDULE 13GBeneficial Ownership Report0001231919-26-000398Apr 23, 2026 9:33 PM
404Insider Transaction0001835208-26-000003Apr 23, 2026 8:16 PM
41144Insider Transaction0001835208-26-000001Apr 21, 2026 12:22 AM
42PRE 14AOthers0001628280-26-026053Apr 20, 2026 9:21 PM
438-KCurrent Report0001193125-26-157140Apr 15, 2026 8:35 PM
44424B5Prospectus0001193125-26-157128Apr 15, 2026 8:33 PM
45424B5Prospectus0001193125-26-152989Apr 13, 2026 8:44 PM
468-KCurrent Report0001193125-26-152866Apr 13, 2026 8:09 PM
478-KCurrent Report0001193125-26-151999Apr 13, 2026 11:45 AM
484Insider Transaction0002057918-26-000007Apr 2, 2026 8:47 PM
49144Insider Transaction0002057918-26-000005Apr 1, 2026 11:13 PM
504Insider Transaction0001737287-26-000015Mar 18, 2026 8:06 PM
...

Allogene Therapeutics, Inc. SEC Filings API

Pull Allogene Therapeutics, Inc.'s SEC filing index, with links to every filing and exhibit, into your own tools with the Business Quant SEC Filings API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/secfilings?ticker=ALLO&formtype=10-K,10-Q&api_key=YOUR_API_KEY